Five Below’s Strong Quarter Tests How Far Its Growth Model Can Scale

  • Five Below (NasdaqGS:FIVE) reported strong first quarter results, with higher net sales, earnings, and comparable sales.
  • The company opened 49 new stores during the quarter, reflecting faster expansion of its store base.
  • Management raised full year revenue and earnings guidance, signaling confidence in the current growth plan.

Five Below focuses on value oriented specialty retail, targeting younger shoppers with a wide range of low price discretionary items. The latest update comes at a time when many consumers are paying close attention to price, and discount focused retailers are attracting interest from investors. In this context, fresh details on store openings and same store sales can help you gauge how this retailer is competing within value driven retail.

For investors watching NasdaqGS:FIVE, the combination of stronger quarterly results, faster store openings, and higher full year guidance provides new information about how the current expansion plan is progressing. The next steps will likely center on whether the company can sustain broad based sales performance across new and existing stores while managing costs as the footprint grows.

Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page.

NasdaqGS:FIVE Earnings & Revenue Growth as at Jun 2026
NasdaqGS:FIVE Earnings & Revenue Growth as at Jun 2026

2 things going right for Five Below that this headline doesn't cover.

For you as an investor, this update ties directly to how scalable Five Below’s model looks today. Net sales of US$1.29b and net income of US$123.06m for the first quarter point to meaningful operating leverage, with diluted EPS of US$2.21 vs. US$0.75 a year ago. Management is now planning about 150 net new stores in fiscal 2026 and is guiding to full year net sales of US$5.40b to US$5.48b and diluted EPS of US$8.62 to US$9.02. That combination of higher guidance and faster store openings suggests the current store format and merchandising approach are working across a wide geography.

The raised outlook for the second quarter, including expected net sales of US$1.18b to US$1.20b and 7% to 9% comparable sales growth, also indicates that management expects recent momentum to carry through at least the near term. For a discount-focused retailer competing with companies like Dollar General, Dollar Tree and Target, broad based comparable sales growth can signal healthy traffic rather than just ticket inflation. At the same time, the after hours share-price drop following the release shows that strong earnings do not always align with short term market reactions, which is a reminder to separate operational progress from near term price moves.

Advertisement

The Risks and Rewards Investors Should Consider

  • ⚠️ Rapid store expansion, with about 150 net new locations planned this year, could strain execution if new sites underperform or if costs per opening move higher.
  • ⚠️ Management has flagged higher fuel, inflation and labor expenses as pressures, which could limit margin improvement even when sales are growing.
  • 🎁 First quarter net sales of US$1.29b and 22.7% comparable sales growth show that both existing and new stores are contributing to a wider revenue base.
  • 🎁 Raised full year guidance for net sales and EPS, alongside raised second quarter guidance, gives you clearer visibility into how management currently views demand and store economics.

What To Watch Going Forward

From here, it is worth tracking whether Five Below can keep comparable sales in the mid single to high single digit range that management has built into guidance while opening roughly 150 net new stores. Watch store productivity, particularly in newer markets, and any commentary on traffic versus average ticket so you can see if growth is coming from more shoppers or just higher prices. Given cost headwinds, updates on gross margin and labor spending will also matter for assessing how much of the stronger sales flow through to earnings.

To ensure you're always in the loop on how the latest news impacts the investment narrative for Five Below, head to the community page for Five Below to never miss an update on the top community narratives.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NasdaqGS:FIVE

Five Below

Operates as a specialty value retailer in the United States.

Flawless balance sheet with solid track record.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
50 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
WE
WealthAP
NOVO B logo
WealthAP on Novo Nordisk ·

Novo Nordisk (NVO): Is the "Easy Growth" Story Over?

Fair Value:DKK 407.7719.9% undervalued
69 users have followed this narrative
0 users have commented on this narrative
8 users have liked this narrative
VA
ValueInvestingSubstack
ZTS logo
ValueInvestingSubstack on Zoetis ·

Zoetis down -50% over the past year

Fair Value:US$92.9217.2% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
CE
CentryResearch
LEU logo
CentryResearch on Centrus Energy ·

Centrus Energy: The Next Nuclear Bottleneck Isn't Reactors. It's Fuel.

Fair Value:US$1907.4% undervalued
24 users have followed this narrative
0 users have commented on this narrative
11 users have liked this narrative

Updated Narratives

FE
PASS3 logo
FernandoLeal on Compass Gas e Energia ·

Compass Gas e Energia has a reliable dividend, with a consistent moat, high free cash flow margins and will expand to two digits net margin.

Fair Value:R$40.9438.2% undervalued
2 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
Brunhilde_Wagner
CPRT logo
Brunhilde_Wagner on Copart ·

Compounder to Cash Generator in Real Time

Fair Value:US$2710.3% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
WI
WisetoWealth
PYPL logo
WisetoWealth on PayPal Holdings ·

The Underrated Transformation of a Digital Payments Giant

Fair Value:US$90.3137.9% undervalued
6 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
84 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
192 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
72 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0
AN
CSMG3 logo
andre_k1tsg on Companhia de Saneamento de Minas Gerais ·

Gostei

0
|
0